Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Placeholder Photo
Robyn Bent, RN, CAPT
PATIENT FOCUSED DRUG DEVELOPMENT PROGRAM DIRECTOR, CDER, FDA
Enhancing Meaningful Engagement on Patient Experience Data in Drug Development
Cory Berkland, PhD
CEO, BOND BIOSCIENCES
Bond Biosciences
Saint Louis, Missouri, United States
Rob Berlin, JD
HEAD - U.S. REGULATORY POLICY, GSK
Re-Imagining Drug Development and Regulatory Submissions through Cloud-Based Technologies
Washington DC, District of Columbia, United States
Nicole Berry
SVP, HEAD OF AMERICAS REGION, ILLUMINA
Scaling Approved Patient-Centered Therapies: Resolving the Diagnostic Challenge
Alexandra Beumer Sassi, PhD, RAC
SENIOR DIRECTOR CMC&QUALITY, VOISIN CONSULTING LIFE SCIENCES
Former FDA Reviewers Panel: Perspectives on Cell and Gene Therapy Development from Inside and Outside the FDA
Michael Bevilacqua, MD
CEO, CSO, DIRECTOR, & CO-FOUNDER, MACRO BIOLOGICS
Macro Biologics
Carlsbad, California, United States
Abhijit Bhatia, MBA
CHIEF OPERATING OFFICER, RAKUTEN MEDICAL, INC.
Rakuten Medical, Inc.
San Diego, California, United States
Rupal Bhatt
VP, SOLID TUMOR ONCOLOGY, BRISTOL MYERS SQUIBB
Perspectives on Target Selection: How Companies Approach a Critical Decision
Sulagna Bhattacharya, MBA
CEO, NANOSCOPE THERAPEUTICS
Nanoscope Therapeutics
DALLAS, Texas, United States
Laurent Bili
AMBASSADOR TO THE UNITED STATES, FRANCE
Spurring Life Sciences Innovation Across The Globe: A High-Level Discussion